StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.87+0.26 (+5.64%)

Close on Nov 18, 2026Market cap $61.16MP/E –Yield –

Neuraxis total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Neuraxis's total debt was $42.73K at Jun 30, 2026. For fiscal 2025 it was $148.29K, down 3.8% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$148.29K-3.8%
FY2024Dec 31, 2024$154.15K+4.1%
FY2023Dec 31, 2023$148.06K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$42.73K-64.8%
Q1 FY2026Mar 31, 2026$100.74K+19.5%
Q4 FY2025Dec 31, 2025$148.29K-3.8%
Q3 FY2025Sep 30, 2025$195.66K+32.5%
Q2 FY2025Jun 30, 2025$121.43K-97.5%
Q1 FY2025Mar 31, 2025$84.31K-94.0%
Q4 FY2024Dec 31, 2024$154.15K+4.1%
Q3 FY2024Sep 30, 2024$147.69K-23.9%
Q2 FY2024Jun 30, 2024$4.77M+209.8%
Q1 FY2024Mar 31, 2024$1.40M–
Q4 FY2023Dec 31, 2023$148.06K–
Q3 FY2023Sep 30, 2023$194.00K–
Q2 FY2023Jun 30, 2023$1.54M–

More Neuraxis figures

See a number that looks wrong?